Got a tip?:

Posts Tagged ‘Drug Administration’

Bristol-Myers Just Received FDA Approval for Small Cell Lung Cancer Drug

Bristol-Myers announced that its Opdivo (nivolumab) has received approval from the U.S. Food and Drug Administration as the first and only Immuno-Oncology treatment option for patients with metastatic small cell lung cancer (SCLC) whose cancer has progressed after platinum-based chemotherapy and at least one other line of therapy. According to the American Cancer Society, and…

Read More